Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page
Latest predictions
-
24.06.20
buy
€37.50
12.09.19
€57.50
19.08.19
buy
Your prediction

Eckert & Ziegler Strahlen- und Medizintechnik AG Stock

The price for the Eckert & Ziegler Strahlen- und Medizintechnik AG stock decreased slightly today. Compared to yesterday there is a change of -€0.240 (-0.570%).
With 2 Buy predictions and 1 Sell predictions the community is currently undecided on Eckert & Ziegler Strahlen- und Medizintechnik AG.
With a target price of €47.00 there is a slightly positive potential of 12.011% for Eckert & Ziegler Strahlen- und Medizintechnik AG compared to the current price of €41.96.

Comments

Published 28.01.20
Prediction Buy
Perf. (%) -2.474%
Target price
Change

Buy beendet

Published 14.12.19
Prediction Buy
Perf. (%) 12.469%
Target price
Change

Buy beendet

Buy Eckert & Ziegler AG

Show more
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more

Other discussions about Eckert & Ziegler Strahlen- und Medizintechnik AG Stock

New thread Forum

News

DGAP-News: Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020

DGAP-News: Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020

DGAP-Adhoc: Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

DGAP-Adhoc: Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

DGAP-News: Q1 Performance Stable despite Oil Price Slump and Corona Expenses. Strong Growth in Radiopharmaceutical Products

DGAP-News: Q1 Performance Stable despite Oil Price Slump and Corona Expenses. Strong Growth in Radiopharmaceutical Products

DGAP-News: US health authorities to provide USD 6 million in funding for MYELO radiation protection pill

DGAP-News: US health authorities to provide USD 6 million in funding for MYELO radiation protection pill

DGAP-News: Eckert & Ziegler Enters TecDAX

DGAP-News: Eckert & Ziegler Enters TecDAX

DGAP-News: Eckert & Ziegler with Record Profit in FY 2019

DGAP-News: Eckert & Ziegler with Record Profit in FY 2019

DGAP-Adhoc: Eckert & Ziegler: Executive Board Proposes Dividend and Share Split

DGAP-Adhoc: Eckert & Ziegler: Executive Board Proposes Dividend and Share Split

DGAP-News: Eckert & Ziegler receives CE approval for innovative irradiation applicators using 3D printing

DGAP-News: Eckert & Ziegler receives CE approval for innovative irradiation applicators using 3D printing

DGAP-News: Eckert & Ziegler Classified in California as Essential Business

DGAP-News: Eckert & Ziegler Classified in California as Essential Business

DGAP-News: Eckert & Ziegler Starts Commercial Production of Lutetium-177

DGAP-News: Eckert & Ziegler Starts Commercial Production of Lutetium-177

DGAP-Adhoc: Eckert & Ziegler Reorganizes its Production Sites

DGAP-Adhoc: Eckert & Ziegler Reorganizes its Production Sites

DGAP-News: Eckert & Ziegler to Financially Back Clinical Development of Innovative Lymphoma Treatment

DGAP-News: Eckert & Ziegler to Financially Back Clinical Development of Innovative Lymphoma Treatment

DGAP-News: ​​​​​​​Eckert & Ziegler: Earnings per Share Rise to EUR 4.29 According to Preliminary Figures

DGAP-News: ​​​​​​​Eckert & Ziegler: Earnings per Share Rise to EUR 4.29 According to Preliminary Figures

DGAP-News: Eckert & Ziegler Starts Development Cooperation for Prostate Cancer Diagnosis

DGAP-News: Eckert & Ziegler Starts Development Cooperation for Prostate Cancer Diagnosis